Human medicines European public assessment report (EPAR): Alli (previously Orlistat GSK), orlistat, Obesity, Date of authorisation: 22/07/2007, Revision: 16, Status: Authorised

2018 Case Medical Research  
doi:10.31525/cmr-5871a1 fatcat:mc4j2bxhrrda3ks6zbkkeavmey